These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 29218823)
1. Perspectives of cannabis use in the life experience of men with schizophrenia. Wagstaff C; Graham H; Farrell D; Larkin M; Tatham L Int J Ment Health Nurs; 2018 Jun; 27(3):1099-1108. PubMed ID: 29218823 [TBL] [Abstract][Full Text] [Related]
2. Experiences of mental health services for 'black' men with schizophrenia and a history of disengagement: A qualitative study. Wagstaff C; Graham H; Farrell D; Larkin M; Nettle M Int J Ment Health Nurs; 2018 Feb; 27(1):158-167. PubMed ID: 28019715 [TBL] [Abstract][Full Text] [Related]
3. Qualitative experiences of disengagement in assertive outreach teams, in particular for "black" men: Clinicians' perspectives. Wagstaff C; Graham H; Salkeld R J Psychiatr Ment Health Nurs; 2018 Mar; 25(2):88-95. PubMed ID: 29130607 [TBL] [Abstract][Full Text] [Related]
4. The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. Costain WF Int J Ment Health Nurs; 2008 Aug; 17(4):227-35. PubMed ID: 18666905 [TBL] [Abstract][Full Text] [Related]
5. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298 [TBL] [Abstract][Full Text] [Related]
6. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. van Dijk D; Koeter MW; Hijman R; Kahn RS; van den Brink W Schizophr Res; 2012 May; 137(1-3):50-7. PubMed ID: 22313726 [TBL] [Abstract][Full Text] [Related]
7. Craving in patients with schizophrenia and cannabis use disorders. Schnell T; Becker T; Thiel MC; Gouzoulis-Mayfrank E Can J Psychiatry; 2013 Nov; 58(11):646-9. PubMed ID: 24246436 [TBL] [Abstract][Full Text] [Related]
8. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Andréasson S; Allebeck P; Rydberg U Acta Psychiatr Scand; 1989 May; 79(5):505-10. PubMed ID: 2787581 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects. Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823 [TBL] [Abstract][Full Text] [Related]
10. The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services. Libuy N; de Angel V; Ibáñez C; Murray RM; Mundt AP Schizophr Res; 2018 Apr; 194():13-17. PubMed ID: 28427930 [TBL] [Abstract][Full Text] [Related]
11. Risk-taking in schizophrenia and controls with and without cannabis dependence. Fischer BA; McMahon RP; Kelly DL; Wehring HJ; Meyer WA; Feldman S; Carpenter WT; Gorelick DA Schizophr Res; 2015 Feb; 161(2-3):471-7. PubMed ID: 25467541 [TBL] [Abstract][Full Text] [Related]
12. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Coulston CM; Perdices M; Tennant CC Schizophr Res; 2007 Nov; 96(1-3):169-84. PubMed ID: 17826035 [TBL] [Abstract][Full Text] [Related]
13. Neurocognitive functioning and cannabis use in schizophrenia. Segev A; Lev-Ran S Curr Pharm Des; 2012; 18(32):4999-5007. PubMed ID: 22716156 [TBL] [Abstract][Full Text] [Related]
14. The effects of cannabis use on the clinical condition of schizophrenics. Negrete JC; Knapp WP NIDA Res Monogr; 1986; 67():321-7. PubMed ID: 3092086 [No Abstract] [Full Text] [Related]
15. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Rabin RA; Zakzanis KK; George TP Schizophr Res; 2011 May; 128(1-3):111-6. PubMed ID: 21420282 [TBL] [Abstract][Full Text] [Related]
16. Effects of cannabis abuse on people with serious mental health problems. Gray R; Thomas B Br J Nurs; 1996 Feb 22-Mar 13; 5(4):230-3. PubMed ID: 8704453 [TBL] [Abstract][Full Text] [Related]
17. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935 [TBL] [Abstract][Full Text] [Related]
18. Natural Recovery From Cannabis Use in People With Psychosis: A Qualitative Study. Rebgetz S; Hides L; Kavanagh DJ; Choudhary A J Dual Diagn; 2015; 11(3-4):179-83. PubMed ID: 26458187 [TBL] [Abstract][Full Text] [Related]
19. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864 [TBL] [Abstract][Full Text] [Related]
20. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Dubertret C; Bidard I; Adès J; Gorwood P Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]